46th week of 2011 patent applcation highlights part 48 |
Patent application number | Title | Published |
20110281907 | COMPOSITIONS AND METHODS FOR INHIBITION OF HEPATOCYTE GROWTH FACTOR RECEPTOR C-MET SIGNALING - Derivatives and analogs of inhibitors of receptor tyrosine kinase c-Met obtained by virtual screening, pharmaceutical compositions containing derivatives and analogs of c-Met inhibitors are provided. Methods of making derivatives and analogs of c-Met inhibitors and methods of use thereof are provided. Formula (I) | 2011-11-17 |
20110281908 | Aminoquinoline Derived Heat Shock Protein 90 Inhibitors, Methods Of Preparing Same, And Methods For Their Use - Novel classes of molecular chaperone Heat shock protein 90 (Hsp90) inhibitors and methods for making these classes are provided herein. These compounds are useful in treating and preventing cancer and other Hsp90-related diseases, such as inflammation and neurodegenerative disorders. Also provided herein are methods of treating and preventing cancer and other Hsp90 related disease. The methods include administering to a subject a therapeutically effective amount of an Hsp90 inhibitor. | 2011-11-17 |
20110281909 | SUBSTITUTED QUINOLINE DERIVATIVES AS H1 RECEPTOR ANTAGONISTS - The present invention relates to compounds of formula (I), | 2011-11-17 |
20110281910 | Hepatitis C Virus Inhibitors - This disclosure concerns novel compounds of Formula (I) or as defined in the specification and compositions comprising such novel compounds. These compounds are useful antiviral agents, especially in inhibiting the function of the NS5A protein encoded by Hepatitis C virus (HCV). Thus, the disclosure also concerns a method of treating HCV related diseases or conditions by use of these novel compounds or a composition comprising such novel compounds. | 2011-11-17 |
20110281911 | NOVEL FORMS OF EPERISONE - The invention relates to substantially enantiopure crystalline salt forms of (2RS)-I-(4-Ethylphenyl)-2-methyl-3-piperidin-1-ylpropan-1-one. The preparation and characterization of the substantially enantiopure crystalline salt forms according to various embodiments of the invention is described. The invention also relates to pharmaceutical compositions containing the substantially enantiopure crystalline salt forms, which are useful to treat and/or prevent various conditions such as pathological muscle contracture, myotome conditions, and spastic paralysis or spasticity caused by various neurologic conditions, and are also useful for the treatment and/or prevention of various types of pain and pathological muscle tension. | 2011-11-17 |
20110281912 | ORAL DISPERSIBLE TABLET - The present invention relates to an oral dispersible tablet comprising at least one filler selected from sugars and sugar alcohols, and microcrystalline cellulose. | 2011-11-17 |
20110281913 | MELANOCORTIN RECEPTOR ANTAGONIST COMPOUNDS, PROCESS FOR PREPARING THEM AND USE THEREOF IN HUMAN MEDICINE AND COSMETICS - Melanocortin receptor antagonist compounds, processes for preparing them and uses thereof in human medicine and cosmetics are described. | 2011-11-17 |
20110281914 | FENTANYL COMPOSITION FOR NASAL ADMINISTRATION - The treatment of acute pain with a sufficient dosage by intranasal administration of fentanyl results in a time to onset of action comparable to intravenous administration and a significantly faster onset of action than nasal titration of fentanyl. The nasal administration of a sufficient amount of fentanyl to obtain pain relief has lower maximum plasma concentrations comparable to intravenous administration and results in lower rates of adverse events like respiratory depression, nausea and vomiting. Compositions for use in the method are also disclosed. | 2011-11-17 |
20110281915 | Thienodithiine Derivatives - The present invention relates to new thienodithiine derivatives, to processes for preparing them, to their use for controlling unwanted microorganisms, more particularly phytopathogenic fungi, in crop protection, in the household and hygiene sector and in the protection of materials, and also to crop protection compositions comprising these thienodithiine derivatives. | 2011-11-17 |
20110281916 | MIGRASTATIN ANALOGS AND USES THEREOF - The present invention provides compounds having formula (I): | 2011-11-17 |
20110281917 | Substituted Benzimidazoles for the Treatment of Astrocytomas - The present invention relates to the use of BENZIMIDAZOLE DERIVATIVES for the preparation of a drug for the treatment of astrocytomas. | 2011-11-17 |
20110281918 | Antifungal Composition - A pharmaceutical composition for oral administration which is self-emulsifying on contact with an aqueous phase, in particular gastrointestinal fluids, and which comprises: (a) an antifungally active compound of formula (I) wherein R | 2011-11-17 |
20110281919 | AGENT FOR TREATING OR PREVENTING DIGESTIVE ULCER - An object of the present invention is to provide an agent for treating or preventing digestive ulcer that is effective even to ulcer of small intestine and others, for which gastric acid secretion inhibitors such as proton pump inhibitors are ineffective, and is superior to allopurinol in the efficaciousness and the safety. | 2011-11-17 |
20110281920 | INJECTABLE PARASITICIDAL FORMULATIONS OF LEVAMISOLE AND MACROCYCLIC LACTONES - The present invention provides levamisole/macrocyclic lactone-containing injectable formulations that are effective against animal pests, including endoparasites. The formulations may be used for combating parasites in or on birds and mammals. The invention also provides for an improved method for eradicating, controlling and preventing parasite infestation of birds and mammals. | 2011-11-17 |
20110281921 | NOVEL ANTI-BIOFILM AGENTS - Novel agents exhibiting anti-biofilm formation activity while being non-cytotoxic are provided, as well as methods of using the same, either per se or conjugated to a polymer, for preventing and/or reducing the formation of microbial biofilms and/or for disrupting microbial biofilms. The novel agents described herein include thiazolidine-2,4-diones (TZDs), pyrrolidine-2,5-diones (PYDs), imidazolidine-2,4-diones or oxazolidine-2,4-diones, substituted by an alkyl having 7-20 carbon atoms in its backbone chain. | 2011-11-17 |
20110281922 | AMIDE THIAZOLE DERIVATIVE, PREPARATION METHOD AND USES THEREOF - The present invention relates to the field of drugs associated with treating diabetes. Particularly, the present invention relates to a dipeptidyl peptidase-IV inhibitor having the structure shown by formula (I), which contains amide thiazole structure and has an effect on treating diabetes, and a preparation method and a pharmaceutical composition containing it, as well as use thereof in manufacture of the drugs for treating the diabetes, | 2011-11-17 |
20110281923 | ANTAGONISTS OF THE MAGNESIUM BINDING DEFECT AS THERAPEUTIC AGENTS AND METHODS FOR TREATMENT OF ABNORMAL PHYSIOLOGICAL STATES - This invention provides a class of therapeutic compounds and methods for the treatment of mammals with physiological disorders, such as for example a frequently occurring type of essential hypertension, which are critically associated with the decreased binding of magnesium to the plasma membranes of their cells. These methods consist of administering to a mammal in need of such treatment a compound selected from a series of disubstituted trans, trans 1,3-butadienes, 1,3-disubstituted perhydrobutadienes, 1,2-disubstituted trans ethylenes and 1,2 disubstituted ethanes and disubstituted propanes, each of which embodies, in common, the unique structural feature essential for the biological activity of these compounds. This invention also provides for pharmaceutical formulations that employ these novel compounds. | 2011-11-17 |
20110281924 | NOVEL MICROBIOCIDES - Compounds of formula (I), in which the substituents are as defined in claim | 2011-11-17 |
20110281925 | DUAL-ACTING ANTIHYPERTENSIVE AGENTS - The invention is directed to compounds having the formula: | 2011-11-17 |
20110281926 | METHOD FOR DRESSING SEEDS - The present invention relates to a method comprising treating plant propagation material with at least sticker selected from specific acrylate co-copolymers, to seed dressing formulations comprising such stickers and to plant propagation material coated with such stickers. | 2011-11-17 |
20110281927 | DEUTERIUM-ENRICHED DORIPENEM - The present application describes deuterium-enriched doripenem, pharmaceutically acceptable salt forms thereof, and methods of treating using the same. | 2011-11-17 |
20110281928 | Process for the preparation of zofenopril and its pharmaceutically acceptable salts thereof - The present invention relates to a process for the preparation of zofenopril and its pharmaceutically acceptable salts and a pharmaceutical composition thereof. The present invention also provides structurally novel compounds, which are useful intermediates in the synthesis of zofenopril. | 2011-11-17 |
20110281929 | Pharmaceutical Compositions Comprising 2-Oxo-1-Pyrrolidine Derivatives - The present invention relates to an immediate release formulation of pharmaceutical compounds. | 2011-11-17 |
20110281930 | Use of 2-Aryl-5-heterocyclyl-cyclohexane-1,3-dione Compounds as Insecticides, Acaricides, and/ or Fungicides - The present invention relates to the use of compounds of Formula (I) wherein R | 2011-11-17 |
20110281931 | RNA SEQUENCE-SPECIFIC MEDIATORS OF RNA INTERFERENCE - The present invention relates to a Drosophila in vitro system which was used to demonstrate that dsRNA is processed to RNA segments 21-23 nucleotides (nt) in length. Furthermore, when these 21-23 nt fragments are purified and added back to Drosophila extracts, they mediate RNA interference in the absence of long dsRNA. Thus, these 21-23 nt fragments are the sequence-specific mediators of RNA degradation. A molecular signal, which may be their specific length, must be present in these 21-23 nt fragments to recruit cellular factors involved in RNAi. This present invention encompasses these 21-23 nt fragments and their use for specifically inactivating gene function. The use of these fragments (or chemically synthesized oligonucleotides of the same or similar nature) enables the targeting of specific mRNAs for degradation in mammalian cells, where the use of long dsRNAs to elicit RNAi is usually not practical, presumably because of the deleterious effects of the interferon response. This specific targeting of a particular gene function is useful in functional genomic and therapeutic applications. | 2011-11-17 |
20110281932 | Methods to enhance T-cell mediated immune response - The present invention provides methods for restoring or enhancing T cell mediated immune response in individuals of middle and advanced age. | 2011-11-17 |
20110281933 | METHODS AND COMPOSITIONS FOR THE MANAGEMENT OF CARDIOVASCULAR DISEASE WITH OLIGONUCLEOTIDES - Disclosed are compositions and methods for treating cardiovascular disease and reducing the adverse effects induced by the administration of statins. In particular, disclosed is the use of antisense compounds to augment the expression of mirR-33 and associated genetic elements. In particular methods of the treatment of cardiovascular disease and the modulation of miR-33 levels is disclosed as well as treatment of the secondary effects including cholestasis, induced by the administration of statins is disclosed. Also disclosed is the treatment of Benign Recurrent Intrahepatic Cholestasis and reverse cholesterol transport. The disclosed methods and compositions may be practiced separately or co-administered with satins to reduce or treat statin induced secondary effects. | 2011-11-17 |
20110281934 | MICELLES OF HYDROPHILICALLY SHIELDED MEMBRANE-DESTABILIZING COPOLYMERS - Provided herein are micelles comprising a plurality of copolymers. In certain instances, micelles provided herein are pH sensitive particles. | 2011-11-17 |
20110281935 | Combination Therapy Based on SRC and Aurora Kinase Inhibition for the Treatment of Cancer - Compositions which act synergistically to inhibit the growth of cancer cells and methods of use thereof are disclosed. | 2011-11-17 |
20110281936 | METHODS OF TREATING COGNITIVE DISORDERS BY INHIBITION OF GPR12 - The present invention provides methods for screening a pharmaceutical agent for its ability to modulate long term memory formation, performance of a hippocampal-dependent cognitive task or Gpr12 function. The present invention also provides methods for modulating long term memory formation or performance of a hippocampal-dependent cognitive task by modulating Gpr12-dependent protein expression. The present invention further provides methods for treating a defect in long term memory formation by inhibiting Gpr12 function and methods for treating a defect in performance of a hippocampal-dependent cognitive task by inhibiting Gpr12 function. | 2011-11-17 |
20110281937 | Methods and compositions for treating neuropathic and neurodegenerative conditions - Disclosed herein are engineered zinc finger proteins which modulate transcription of the gene encoding vascular endothelial growth factor-A (VEGF-A) and other genes encoding products with neurotrophic activities. Also disclosed are methods for the use of these engineered zinc finger proteins in the treatment of neuropathy (including diabetic neuropathy), and other types of neural injury and neurodegeneration. | 2011-11-17 |
20110281938 | APTAMERS TO TISSUE FACTOR PATHWAY INHIBITOR AND THEIR USE AS BLEEDING DISORDER THERAPEUTICS - The invention relates generally to the field of nucleic acids and more particularly to aptamers that bind to TFPI, which are useful as therapeutics in and diagnostics of bleeding disorders and/or other diseases or disorders in which TFPI has been implicated. In addition, the TFPI aptamers may be used before, during and/or after medical procedures to reduce complications or side effects thereof. The invention further relates to materials and methods for the administration of aptamers that bind to TFPI. | 2011-11-17 |
20110281939 | POLYNUCLEOTIDE APTAMER-BASED CROSS-LINKED MATERIALS AND USES THEREOF - In one aspect, the disclosure provides cross-linked materials that include multivalent polynucleotide aptamers that bind a target molecule; and conjugates that include two or more separate affinity ligands bound to a conjugate framework, wherein the two or more affinity ligands compete with the target molecule for binding with the aptamers and wherein conjugates are cross-linked within the material as a result of non-covalent interactions between aptamers and affinity ligands on different conjugates. These materials are designed to release amounts of conjugate in response to desired concentrations of the target molecule. Depending on the end application, in various embodiments, the conjugates may also include a drug and/or a detectable label. The drug, detectable label and affinity ligands may be covalently or non-covalently bound to the conjugate framework. | 2011-11-17 |
20110281940 | METHOD OF PREPARATION AN INCLUSION-COMPLEX COMPRISING HYDROPHOBIC PHYSIOLOGICAL ACTIVATION MATERIAL INCLUDING WITH CYCLODEXTRIN AND ITS USE - Disclosed herein are a method for preparation of an inclusion-complex including a physiologically active hydrophobic substance in cjclodextrin and a derivative thereof, and use of the inclusion-complex prepared by the same. More particularly, the present invention provides a method for preparing an inclusion-complex, which includes agitating cjclodextrin and a derivative thereof in an agitator at high speed, spraying a physiologically active hydrophobic substance dissolved in alcohol onto the agitator, and drying and crushing the mixture obtained from the preceding step and, in addition, use of the prepared inclusion-complex. The present inventive method has merits of reduced inclusion time and increased inclusion rate. The prepared inclusion-complex has excellent cell and collagen proliferation effects compared to physiologically active hydrophobic substances which were not inclusion processed, thereby being used in production of a cosmetic composition with improved anti-wrinkle and anti-ageing effects. | 2011-11-17 |
20110281941 | COMBINATION OF LYCOPENE, POLYPHENOL, AND VITAMINS FOR THE CARE OF KERATIN MATERIALS - The present invention relates to the cosmetic use, by the oral route, of a combination of lycopene, of vitamin C, of vitamin E and of at least one polyphenol compound derived from pine bark as active ingredient intended for maintaining and/or restoring the biomechanical properties of keratinous materials, and notably of the skin. | 2011-11-17 |
20110281942 | Tautomycetin and Tautomycetin Analog Biosynthesis - The present invention relates to tautomycetin (TTN) and analogs thereof. Also provided are methods of using TTN and analogs thereof in the treatment of various diseases relating to SHP2 function. | 2011-11-17 |
20110281943 | Topical Composition Comprising Ascorbic Acid Derivatives - The present invention discloses topical composition comprising ascorbic acid derivatives. The inventive topical composition that the ascorbic acid derivatives is homogeneously incorporated therein can make the ascorbic acid derivatives more widely used as active ingredient in skin topical formulation. | 2011-11-17 |
20110281944 | METHOD OF A RHEIN COMPOUND FOR INHIBITING PANCREATIC ISLET BETA-CELL DYSFUNCTION AND PREVENTING OR TREATING A PANCREATIC ISLET BETA-CELL DYSFUNCTION RELATED DISORDER - This invention provides a method for inhibiting pancreatic islet β-cell dysfunction, comprising administering to a subject in need thereof an inhibitory effective amount of a rhein compound having the general formula (I) or a pharmaceutically acceptable salt thereof, | 2011-11-17 |
20110281945 | GASTRIC ACID SECRETION INHIBITOR, AND POTASSIUM CHANNEL INHIBITOR - To provide a drug, quasi-drug, food or drink that can act as a gastric acid secretion suppressant or a potassium channel inhibitor by including a composition that can be safely used and can be inexpensively produced. Each of these products contains one or more cooling sensation compositions that are compounds providing cooling sensation in an amount sufficient for exhibiting the efficacy thereof in a living body to which the product is administered. | 2011-11-17 |
20110281946 | POLYMERIC -BASED COMPOSITION - The present invention concerns polymeric-based compositions that are useful in the delivery and sustained release of hydrophobic therapeutic and/or cosmetic agents substantially at the point of injury, infection or, in the case of purely cosmetic applications, the point of treatment. Also provided are methods of preparing such compositions and methods of treatments involving the use of such compositions. | 2011-11-17 |
20110281947 | METHODS OF ADMINISTERING DICLOFENAC COMPOSITIONS FOR TREATING PHOTODAMAGED SKIN - A method of treating at least one dermatological disorder selected from the group consisting of photodamage-induced wrinkles, rosacea, and acne, includes: (a) providing a composition containing 1-3 wt. % diclofenac or a salt thereof, 0.5-1.5 wt. % benzyl alcohol; 10-30 wt. % PEG monomethyl ether, 0.1-3.0 wt. % sodium hyaluronate; and 70-80 wt. % water; and (b) applying the composition to skin of a person in need of the treating in an amount effective to treat the at least one dermatological disorder. | 2011-11-17 |
20110281948 | COSMETIC AND PHARMACEUTICAL FORMULATIONS OF CALIXARENE MOLECULES - The invention relates to the use of calixarenes for preventing or limiting the transfer of an actinide in the body from a site of skin contamination. | 2011-11-17 |
20110281949 | METHODS AND COMPOSITIONS FOR TREATING NEURONAL DAMAGE AND MODULATING TRANSIENT RECEPTOR POTENTIAL CHANNELS - Use of alkyl phenol and monocyclic monoterpene-derived compounds in the treatment of neuronal damage and in inhibiting activity of TRPC and non-thermo-TRPM channels, and use of bicyclic monoterpene-derived compounds in activating TRPC and non-thermo-TRPM channels. | 2011-11-17 |
20110281950 | COMPOSITIONS AND METHODS FOR REDUCING PROLIFERATION AND VIABILITY OF LYMPHOBLASTOID CELLS - Pharmaceutical compositions including an HDAC inhibitor and a pharmaceutically acceptable carrier wherein the HDAC inhibitor is present in an amount sufficient to achieve a plasma concentration from about 100 nM to about 2 uM and methods of treatment using the same. Pharmaceutical compositions including an HDAC inhibitor and a pharmaceutically acceptable carrier wherein the HDAC inhibitor is present in an amount from 0.1 mg to 100 mg. Pharmaceutical compositions including an HDAC inhibitor and a pharmaceutically acceptable carrier, wherein the concentration of the HDAC inhibitor is sufficient to decrease the relative viability of lymphoblastoid cells by at least about 50 percent and/or is sufficient to decrease the proliferation of lymphoblastoid cells by at least about 60 percent and/or is sufficient to decrease the relative viability of peripheral blood mononuclear cells by less than about 50 percent and methods of treatment using the same. | 2011-11-17 |
20110281951 | Compositions and methods for treating amyloidosis - Therapeutic compounds and methods for modulating amyloid aggregation in a subject, whatever its clinical setting, are described. Amyloid aggregation is modulated by the administration to a subject of an effective amount of a therapeutic compound of the formula | 2011-11-17 |
20110281952 | DEUTERIUM-ENRICHED TOLTERODINE - The present application describes deuterium-enriched tolterodine, pharmaceutically acceptable salt forms thereof, and methods of treating using the same. | 2011-11-17 |
20110281953 | PROCESS FOR PREPARING AND DRYING SOLID RASAGILINE BASE - Disclosed is crystalline R(+)-N-propargyl-1-aminoindan containing water at an amount of less than 0.5% by weight and a pharmaceutical composition comprising the same, and the process for the manufacture and the validation thereof. Also disclosed is a process for the preparation of solid rasagiline base. | 2011-11-17 |
20110281954 | METHODS OF SYNTHESIZING CINACALCET AND SALTS THEREOF - Methods of preparing cinacalcet, cinacalcet derivatives, and salts thereof is disclosed herein. Also disclosed herein are polymorphs of cinacalcet, compositions of cinacalcet, and methods of treating a subject by administering cinacalcet, wherein cinacalcet is prepared by the disclosed methods. | 2011-11-17 |
20110281955 | METHODS OF TREATING OBESITY USING ANTIOXIDANT INFLAMMATION MODULATORS - The present invention relates to methods of treating and/or preventing obesity comprising the administration of antioxidant inflammation modulators described herein, including for example bardoxolone methyl. | 2011-11-17 |
20110281956 | USE OF THYMUS CAPITATUS EXTRACT, SATUREJA HORTENSIS EXTRACT, OR CARVACROL FOR TREATING METABOLIC DISEASES - Disclosed is an use of Spanish oregano ( | 2011-11-17 |
20110281957 | ENHANCED BIOACTIVE FORMULATIONS OF RESVERATROL - Methods and formulations for increasing the water solubility and/or bioavailability of resveratrol are disclosed. The formulations may be employed to treat a disease states, including cancer. | 2011-11-17 |
20110281958 | PRODUCTION METHOD YTTRIUM OXIDE-STABILIZED ZIRCONIUM OXIDE SOL - There is provided a production method of an yttrium oxide-stabilized zirconium oxide aqueous sol and organic solvent sol capable of producing a sol having extremely advantageous transparency with which the heating condition is eased compared to that of a conventional method and secondary aggregation of the obtained colloidal particle is hardly caused. A production method of an yttrium oxide-stabilized zirconium oxide aqueous sol, characterized by comprising: a process of subjecting a mixed aqueous solution produced by dissolving an yttrium carboxylate and zirconium oxyacetate in water in an Y/(Y+Zr) atomic ratio in a range of 0.10 to 0.60 to hydrothermal treatment at 160 to 280° C. for 2 hours or more. | 2011-11-17 |
20110281959 | Extraction of Carbon Dioxide and Hydrogen From Seawater and Hydrocarbon Production Therefrom - Apparatus for seawater acidification including an ion exchange, cathode and anode electrode compartments and cation-permeable membranes that separate the electrode compartments from the ion exchange compartment. Means is provided for feeding seawater through the ion exchange compartment and for feeding a dissociable liquid media through the anode and cathode electrode compartments. A cathode is located in the cathode electrode compartment and an anode is located in the anode electrode compartment and a means for application of current to the cathode and anode is provided. A method for the acidification of seawater by subjecting the seawater to an ion exchange reaction to exchange H | 2011-11-17 |
20110281960 | METHOD OF SELECTIVELY REMOVING CATALYST FROM FISCHER-TROPSCH SYNTHETIC CRUDE OIL AND METHOD OF RECYCLING REMOVED CATALYST - A method of selectively removing a Fischer-Tropsch catalyst from a Fischer-Tropsch synthetic crude oil is provided, the method including the steps of extracting a slurry, containing a Fischer-Tropsch catalyst having magnetism and Fischer-Tropsch synthetic crude oil obtained by a Fischer-Tropsch synthesis reaction, from a Fischer-Tropsch synthesis reactor; separating a catalyst having a predetermined diameter or more from the slurry by means of a first solid-liquid separator; and separating a catalyst which is not be separated by means of the first solid-liquid separator from the slurry from which the catalyst having the predetermined diameter or more is removed, by means of a second solid-liquid separator. | 2011-11-17 |
20110281961 | Process for the conversion of synthesis gas to oxygenates - The present invention relates to an improved process for the conversion of carbon oxide(s) et hydrogen containing feedstocks to oxygen containing hydrocarbon compounds in the presence of a particulate catalyst. In particular, the present invention relates to an improved process for the conversion of carbon oxide(s) (CO et CO2) et hydrogen containing feedstocks, e.g. Synthesis gas or syngas, to alcohols in the presence of a particulate modified molybdenum sulphide based catalyst and/or a modified methanol based catalyst and/or a modified Fischer-Tropsch catalyst and/or a precious metal based catalyst (e.g. rhodium). | 2011-11-17 |
20110281962 | FRICTION MATERIAL AND PRODUCTION METHOD OF FRICTION MATERIAL - A friction material including: an amorphous resin that has a chain-like polymer structure; and other components that constitute the friction material and that are components other than the amorphous resin, wherein dispersion treatment is preliminarily carried out in which the amorphous resin is dispersed in at least one of the other components, and a manufacturing method of the friction material. | 2011-11-17 |
20110281963 | POLYPROPYLENE RESIN PRE-FOAMED PARTICLE AND METHOD FOR PRODUCING SAME, AND POLYPROPYLENE RESIN IN-MOLD FOAMING MOLDED ARTICLE - Provided are polypropylene resin pre-foamed particles including, as base resin, polypropylene resin that satisfies the following requirements (a) through (c): (a) in cross fractionation chromatography, an amount of components eluted at a temperature of not more than 40° C. is not more than 2.0% by weight; (b) a melting point is not less than 100° C. but not more than 160° C.; and (c) propylene monomer units are present in an amount of not less than 90 mol % but not more than 100 mol %, and olefin units each having a carbon number of 2 or 4 or more are present in an amount of not less than 0 mol % but not more than 10 mol %. The polypropylene resin pre-foamed particles can be molded by in-mold foaming molding at a not high molding heating steam pressure, and a polypropylene resin in-mold foaming molded product excellent in dimensional stability at high temperatures can be prepared from the polypropylene resin pre-foamed particles. | 2011-11-17 |
20110281964 | Process for preparing foamable polymer compositions, process for preparing foamed polymer compositions therefrom, foamed polymer compositions and adhesive tape therewith - The invention relates to a process for preparing a foamed polymer composition using expandable hollow microbeads,
| 2011-11-17 |
20110281965 | POLYURETHANE CASTING COMPOUNDS - The invention relates to the use of polyurethane casting compounds for producing light-resistant compact or expanded polyurethane or polyurethane urea bodies that are characterized by exceptionally good mechanical and visual properties and particularly have a very high heat shape retention. | 2011-11-17 |
20110281966 | POLYURETHANE SEALING COMPOUNDS - The invention relates to the use of polyurethane sealing compounds for the production of light-fast compact or foamed polyurethane bodies or polyurethane urea bodies which have excellent mechanical and optical properties and especially a very high thermostability. | 2011-11-17 |
20110281967 | Encapsulant for Inkjet Print Head - A UV curable composition suitable for use as an encapsulant to protect silicon semiconductor dies and their electrical bonding on digital print heads comprises an acrylate and/or methacrylate ((meth)acrylate) oligomer, preferably a difunctional oligomer; a diluent, preferably a (meth)acrylate; a tri-functional or tetra-functional thiol; a polypropylene oxide/butylene oxide block polymer; and a photoinitiator. | 2011-11-17 |
20110281968 | Polymerizable Contact Lens Formulations And Contact Lenses Obtained Therefrom - Contact lenses, such as hydrogel contact lenses, are described. The present contact lenses include a lens body that is the reaction product of a polymerizable composition. The polymerizable composition includes one or more monomers and a crosslinker that crosslinks the one or more monomers during polymerization. The polymerization of the one or more monomers occurs in the presence of a hydrophilic polymer that is present in the polymerizable composition, which comprises a polymer of 2-methacryloyloxyethyl phosphorylcholine. The present lenses are capable of releasing the hydrophilic polymer from the contact lens for prolonged periods of time and also have a reduced surface friction compared to similar lenses without the hydrophilic polymer. The present invention also relates to packaging systems for use with such lenses and methods of producing such lenses. | 2011-11-17 |
20110281969 | COMPOUNDS WITH GUANIDINE STRUCTURE AND USES THEREOF AS ORGANOPOLYSILOXANE POLYCONDENSATION CATALYSTS - A compound having a guanidine structure and uses thereof as organopolysiloxane polycondensation catalysts are described. | 2011-11-17 |
20110281970 | CELLULOSE ETHER COMPOSITION FOR DRY MORTAR FORMULATIONS - The present invention relates to a cellulose ether composition for use in the preparation of dry mortar formulations, especially of cementitious bound tile adhesives (CBTA). The invention further relates to a dry mortar formulation comprising said cellulose ether composition. Furthermore, the invention is directed to a method of improving the slip resistance of a dry mortar formulation without deteriorating the mechanical strength and the open time of the cured dry mortar formulation. | 2011-11-17 |
20110281971 | TRANSPARENT COLOR COATING COMPOSITION CONTAINING NANOSIZE DISPERSED PIGMENTS, COATED SUBSTRATE AND METHOD FOR PREPARING SAME - The present invention relates to a transparent color coating composition containing nano-sized dispersed pigments, to a coated substrate, and to a method for preparing the same. When used in coating glass, the transparent color coating composition expresses a variety of colors, maintains continuous color transparency, gives sun protection to glass, and has superior adhesion, solvent resistance, and sun protection properties. | 2011-11-17 |
20110281972 | POWDER COATING COMPOSITIONS FOR LOW TEMPERATURE CURING AND HIGH FLOW - The present invention relates to powder coating compositions and to components and ingredients for incorporation therein, suitable for low temperature curing schedule and with excellent resistance to outside aging. The powder coating composition can be cured at a temperature from 140° C. to lead to a coating with excellent flow and high gloss. | 2011-11-17 |
20110281973 | Novel particles and composite particles, their uses and a novel process for producing them from alkoxysilyl-group-carrying alkoxylation products - Novel particles and composite particles, their uses and a novel process for producing them from alkoxysilyl-group-carrying alkoxylation products. | 2011-11-17 |
20110281974 | PROCESS FOR PRODUCING COMPOSITION OF POLYMERIZABLE ORGANIC COMPOUND CONTAINING SILICA PARTICLES - A process for producing a composition of a polymerizable organic compound containing silica particles characterized by comprising: (a) a process of preparing an amine-added organic solvent-dispersed silica sol, in which an amine compound is added to an organic solvent-dispersed silica sol that contains colloidal silica particles having an average primary particle size of 5 to 100 nm and that has a pH of 2.5 to 4.0 at 20° C. as measured in a diluted solution obtained by a method in which the same mass of the organic solvent-dispersed silica sol, methanol, and pure water are mixed together, so that the diluted solution obtained by the mixing method has a pH of 4.5 to 11.0 at 20° C.; and (b) a process of mixing the amine-added organic solvent-dispersed silica sol obtained in the process (a) with a polymerizable organic compound. | 2011-11-17 |
20110281975 | Method for Producing Phosphated Polycondensation Products and the Use Thereof - The invention relates to a process for the preparation of a phosphated polycondensate, at least one sulphonic acid being used as catalyst, and to the use of the phosphated polycondensate obtained as an admixture for aqueous suspensions of hydraulic and/or latently hydraulic binders. | 2011-11-17 |
20110281976 | REDISPERSIBLE POWDER COMPOSITION FOR DRY MORTAR FORMULATIONS - The present invention relates to a redispersible powder composition for use in the preparation of dry mortar formulations, especially of cementitious bound tile adhesives (CBTA). The invention further relates to a dry mortar formulation comprising said redispersible powder composition. Furthermore, the invention is directed to a method of increasing the open time of a dry mortar formulation without deteriorating the mechanical strength of the cured dry mortar formulation. | 2011-11-17 |
20110281977 | METHOD FOR FORMING AN ABSORBENT CORE - A method for forming an absorbent core. The method includes the steps of forming and compressing an absorbent core, followed by passing the absorbent core through a subsequent nip between two rolls. At least one of the rolls has a surface including an elastic material, such that the hard-spot number of the absorbent core is reduced. Also, a device for forming absorbent cores as well as absorbent cores produced using the method. | 2011-11-17 |
20110281978 | SUBSTANTIALLY DEFECT-FREE SOUND AND VIBRATION DAMPNING COATING - The present invention is directed to a coating composition comprising: (i) an aqueous dispersion of polymeric particles; (ii) a polyether carbamate compound; (iii) a filler material; and (iv) an inorganic microparticle; and wherein after application to a substrate and after curing, the cured coating composition demonstrates a composite damping Loss Factor of 0.05 or greater at a frequency ranging from 100 to 6,300 Hz and comprises a surface that is substantially free of defects. | 2011-11-17 |
20110281979 | STORING AND DISTRIBUTING A FEEDER PRODUCT - The present invention relates to a process for the preparation of a water-moist cellulose ether composition, characterized in that water-soluble polymeric additives which contain anionic groups (WSAP), or corresponding additive mixtures, are added to the cellulose ether composition. The invention furthermore relates to water-moist cellulose ether compositions which can be prepared by such a process, and to corresponding milled and dried cellulose ether compositions. The invention also relates to the use of these WSAP or corresponding WSAP mixtures for improving the transportability of water-moist cellulose ether compositions in conveying units. | 2011-11-17 |
20110281980 | Thickener composition and method for thickening aqueous systems - A composition and method whereby the same group that is attached to or within the backbone of an associative thickener is reversibly switched between being hydrophilic and hydrophobic in nature. When the group that is attached to or within the backbone is rendered hydrophilic, the aqueous thickener is pourable and readily incorporated into aqueous polymer compositions. When this group is rendered hydrophobic, the thickener performs its thickening function efficiently. Switching is readily accomplished by adjusting the pH of the associative thickener composition and the aqueous polymer composition being thickened. The thickeners may be prepared from monomers by an all-aqueous solution polymerization. | 2011-11-17 |
20110281981 | FIRE RESISTANT MATERIAL - The present invention relates to inorganic-organic hybrids (IOHs), methods for their preparation and their use as fire resistant materials or components of fire resistant materials. More specifically, the invention relates to polyamide fire resistant formulations containing IOHs which have application in the production of fire resistant articles or parts thereof for use in the transportation, building, construction and electrical or optical industries. | 2011-11-17 |
20110281982 | Ultraviolet (UV) Radiation Stability and Service Life of Woven Films of Polypropylene (PP) Tapes for the Production of Jumbo Bags - This invention relates woven jumbo polypropylene bags manufactured from a polypropylene resin that includes a low molecular weight hindered amine light stabilizer, a high molecular weight hindered amine light stabilizer, a first antioxidant, and a second antioxidant. Also provided are methods for the preparation of woven jumbo polypropylene bags. | 2011-11-17 |
20110281983 | Method for the Production of Monohydroxy-Functionalized Dialkylphosphinic Acids, Esters, and Salts Using Ethylene Oxide, and Use Thereof - The invention relates to a method for producing monohydroxy-functionalized dialkylphosphinic acids, esters, and salts, characterized in that a) a phosphinic acid source (I) is reacted with olefins (IV) in the presence of a catalyst A to obtain an alkylphosphonous acid, the salt or ester (II) thereof, b) the, obtained alkylphosphonous acid, the salt or ester (II) thereof is reacted with alkylene oxides of formula (V) in the presence of a catalyst B to obtain a monofunctionalized dialkylphosphinic acid derivative (III), wherein R | 2011-11-17 |
20110281984 | Thermoplastic Elastomer Vulcanizate and Process for Preparing Same - The present invention relates to a thermoplastic elastomer vulcanizate having two respectively thermoplastic and liquid silicone elastomer phases, and the preparation process thereof. The invention also provides a elastomer having
| 2011-11-17 |
20110281985 | DEFOAMING AGENT - The object of the present invention is to provide a defoaming agent that is superior in defoaming properties (foam-breaking, foam-inhibiting effect, defoaming durability). | 2011-11-17 |
20110281986 | WATER-SOLUBLE FLUID FOR USE IN MACHINING OF RARE EARTH MAGNET - A polymeric flocculant is added to an aqueous solution comprising an organic acid and a basic compound to form a water-soluble fluid suitable for use in machining of rare earth magnet. | 2011-11-17 |
20110281987 | Polymer Compositions Comprising Terephthalates - The invention is directed to plasticized compositions comprising esters of terephthalic acid, particularly PVC compositions. | 2011-11-17 |
20110281988 | AQUEOUS INK COMPOSITION AND URETHANE RESIN COMPOSITION FOR AQUEOUS INK COMPOSITION - An object of the present invention is to provide a black ink composition by which a recorded matter in which a fine surface defect on a recorded matter is effectively suppressed, can be obtained. For this object, the present invention is a black ink composition containing water, carbon black, and a water-soluble polyurethane resin, wherein when a content of carbon black is not less than 0.4% by weight and less than 1.5% by weight, a content of a solid matter of the water-soluble polyurethane resin is not less than 0.67-fold and not more than 2.5-fold a content of the carbon black and, when a content of the carbon black is less than 0.4% by weight, a content of a solid matter of the water-soluble polyurethane resin is not less than 7.5-fold a content of the carbon black. | 2011-11-17 |
20110281989 | METHOD FOR PREPARING A TRANSPARENT POLYMER MATERIAL INCLUDING MINDERAL NANOPARTICLES WITH A SHAPE FACTOR STRICTLY HIGHER THAN 1.0 - The present invention provides a method of preparing a transparent polymer material, the method comprising steps i) and ii) in any order, the steps consisting in:
| 2011-11-17 |
20110281990 | POLYAMIDE MOULDING MATERIAL AND USE THEREOF FOR PRODUCTION OF LED HOUSING COMPONENTS - What is described is a polyamide moulding material based on semicrystalline polyamides for production of LED housings or housing components with high strength, high long-term reflectivity and low blistering tendency. The polyamide moulding material proposed consists of the following components | 2011-11-17 |
20110281991 | CORE-SHELL METAL NANOPARTICLES AND METHOD FOR MANUFACTURING THE SAME - A method for manufacturing core-shell metal nanoparticles is provided. The method comprises providing a first solution containing a metal ion; providing a second solution containing Arabinogalactan and having a pH value ranging from about 1 to about 13; mixing the first solution and the second solution to form a third solution; and enabling the third solution to perform an oxidation-reduction reaction to form the core-shell metal nanoparticles. The core-shell metal nanoparticles comprise a core composed of metal; and a shell, composed of Arabinogalactan, covering the surface of he core. | 2011-11-17 |
20110281992 | TOP COAT PAINT, CORROSION RESISTANT SURFACE-TREATED CHAIN AND CORROSION RESISTANT SURFACE-TREATED SPROCKET - The roller chain comprises inner link plates, a bush, outer link plates, a connecting pin, and a roller. Each of the chain components has a zinc-iron alloy ground film formed on an iron-based base material by impact zinc plating and a first coating film formed by using a water-based rust preventive paint including zinc, nitrate, and an organic compound having a mercapto group other than a mercapto group-containing silane coupling agent. Then a second coating film is formed on the first coating film by using the top coat paint comprising a pigment, sodium silicate, and an acrylic emulsion or a polyurethane water-based composition. | 2011-11-17 |
20110281993 | Composites Comprising Polymer and Mesoporous Silicate - Surfactant-templated mesoporous silicates and mesoporous layered silicate clays having certain porosity parameters are used as reinforcing agents for polymers to make composites. The combination of porosity parameters that allows mesoporous silicates to be competitive with organoclays for the reinforcement of engineering polymers include an average mesopore size of at least 2 nm, a surface are of more than about 50 square meters per gram, a total pore volume of more than about 0.33 cubic centimeters per gram, wherein at least 20% of the total pore volume is due to mesopores about 2 to about 50 nm. | 2011-11-17 |
20110281994 | Thermoplastic Elastomer Composition - There is provided a thermoplastic elastomer composition having excellent flexibility, mechanical properties, scratch resistance, abrasion resistance, and low-temperature characteristics. A crosslinked thermoplastic elastomer composition comprising 5 to 70 parts by mass of (C) a hydrogenated product of a block copolymer having at least one conjugated diene monomer unit block and at least one vinyl aromatic monomer unit block, and 20 to 150 parts by mass of (D) an olefin-based resin, based on 100 parts by mass of the total of (A) an ethylene-α-olefin copolymer comprising an ethylene unit and an α-olefin unit having 3 to 20 carbon atoms, and (B) a copolymer having at least one hydrogenated copolymer block mainly composed of a conjugated diene monomer unit and a vinyl aromatic monomer unit, wherein a mass ratio ((A)/(B)) of the (A) component and the (B) component is from 20/80 to 75/25. | 2011-11-17 |
20110281995 | Polycarbonate Resin Composition and Molded Product Using the Same - Disclosed are a polycarbonate resin composition that includes (A) about 5 wt % to about 89 wt % of a polycarbonate resin; (B) about 10 wt % to about 94 wt % of a polycarbonate-polysiloxane copolymer; and (C) about 1 wt % to about 70 wt % of a modified acrylic-based copolymer, and a molded product made using the polycarbonate thermoplastic resin composition. | 2011-11-17 |
20110281996 | METHOD TO ESTABLISH VISCOSITY AS A FUNCTION OF SHEAR RATE FOR IN-SITU POLYMERIZED NANONYLON VIA CHAIN EXTENSION - Chain-extended nanonylon is made from the reaction of in-situ polymerized nanonylon and chain-extending agents. Knowing the viscosity/shear rate curve for a thermoplastic polymer to be replaced, such as nylon, the method of the present invention allows via adjustment of organoclay concentration and chain extension of the nylon polymer and other reaction factors to achieve a chain-extended, in-situ polymerized nanonylon to have a viscosity/shear rate curve that essentially matches the viscosity/shear rate curve for that neat nylon within a commercially operable shear rate. | 2011-11-17 |
20110281997 | POLYANILINE-ADDED PREPOLYMER, METHOD OF MANUFACTURING POLYANILINE-ADDED PREPOLYMER, POLYANILINE GRAFT POLYMER, METHOD OF MANUFACTURING POLYANILINE GRAFT POLYMER, CROSS-LINKED MATERIAL, AND PAINT - Polyaniline is added into a glycidyl group- or isocyanate group-containing (meth)acrylate to obtain a polyaniline-added prepolymer, and then the obtained polyaniline-added prepolymer and another unsaturated group-containing monomer undergo additive copolymerization at their respective double bonds to obtain a polyaniline graft polymer having a weight-average molecular weight of 1,000 to 100,000. | 2011-11-17 |
20110281998 | POLYURETHANE-POLYUREA DISPERSIONS BASED ON POLYCARBONATE-POLYOLS - The invention relates to new, hydrolysis-stable, aqueous polyurethane-polyurea dispersions based on polycarbonate-polyols, to a process for preparing them and to their use in coating materials. | 2011-11-17 |
20110281999 | PROCESS FOR PREPARING AB DIBLOCK COPOLYMERS WITH A BROADLY DISTRIBUTED A BLOCK - The invention relates to a controlled polymerization process for preparing (meth)acrylate-based AB diblock copolymers with a B block which has a narrow monomodal molecular weight distribution, and an A block which has a broad monomodal molecular weight distribution, and to the use thereof, for example, as a binder in adhesives or sealants. | 2011-11-17 |
20110282000 | COPOLYMERS INCLUDING BIOBASED MONOMERS AND METHODS OF MAKING AND USING SAME - Copolymer compositions and methods for making these compositions are described. The copolymers include a vinyl aromatic monomer; a second monomer, and a biobased monomer. The second monomer is selected from the group consisting of butadiene, alkyl acrylates, alkyl methacrylates, and mixtures thereof. Examples of biobased monomers useful in the compositions include isobornyl acrylate, isobornyl methacrylate, tetrahydrofurfuryl acrylate, tetrahydrofurfuryl methacrylate, lauryl acrylate, lauryl methacrylate, and mixtures thereof. The compositions described herein can be used for binder or coating compositions and can include coating pigments, mineral fillers, and other additives. | 2011-11-17 |
20110282001 | FUNCTIONALIZED DIENE RUBBERS - The present invention relates to functionalised diene rubbers and their production, to rubber mixtures, comprising these functionalised diene rubbers, and to their use for the production of rubber vulcanisates, which serve in particular for the production of highly reinforced rubber mouldings. Particular preference is given to the use in the production of tyres which have particularly low rolling resistance, and particularly high wet slip resistance and abrasion resistance. | 2011-11-17 |
20110282002 | COMPOSITION COMPRISING SILYL DERIVATIVE AS DEHYDRATING AGENT - Disclosed is a compositions comprising isocyanate sub-composition comprising by weight not more than 5% of diisocyanate monomers, a dehydrating agent selected among compounds bearing dihydrocarbylsilyl groups bonded to a metalloid of the chalcogen column or to an atom of the nitrogen column. The invention is applicable to the coatings industry, in particular paints and adhesives. | 2011-11-17 |
20110282003 | Free-radical Stable Polymers that are Curable in the Presence of Co-agent - A polymer is described that is stable in the presence of a free-radical initiator, but which cures when subjected to a small amount of free-radical initiator when in the presence of a co-agent. The polymer's main chain comprises polymerized olefin monomers, isobutylene-co-isoprene, or isobutylene-co-methylstyrene. The polymer's side chains comprise a functionality that crosslinks when subjected to a free-radical initiator in the presence of a co-agent. Suitable co-agents include bis-maleimide. Methods for preparing and for crosslinking such polymers are described. Cured product is halo-free and has low odour. | 2011-11-17 |
20110282004 | POLYFUNCTIONAL POLYMER OF HIGH STEREOREGULARITY AND METHOD FOR PRODUCING THE SAME - This invention provides a polyfunctional polymer having high stereoregularity, in particular, isotacticity, and provides a production process thereof. The present invention relates to a polymer having, in a molecule, a repeating unit represented by General Formula (2): | 2011-11-17 |
20110282005 | SUPER-LOW FOULING SULFOBETAINE MATERIALS AND RELATED METHODS - Super-low fouling sulfobetaine and carboxybetaine materials, super-low fouling surfaces and methods of making the surfaces coated with sulfobetaine and carboxybetaine materials, and devices having the super-low fouling surfaces. | 2011-11-17 |
20110282006 | METHOD OF MELT KNEADING, EXTRUDATE, AND TRANSPARENT RESIN MATERIAL - It is an object of the present invention to obtain an optically transparent nano-dispersion polymer blend extrudate and a transparent resin having a microscopic dispersion structure in which incompatible polymer blend is melted and kneaded, one of resins is formed into a matrix, a size of dispersed phase of the other resin is controlled to 300 nm or less, more preferably 100 nm or less. Extra additive such as a compatibilizer is not added. When the incompatible polymer blend is melted and kneaded using a high shearing and forming apparatus having an inner feedback type screw under a condition that the screw rotation speed is 600 rpm to 3000 rpm, the rotation speed of the inner feedback type screw is increased, the kneading time is set under constant rotation speed, the high shearing forming condition is adjusted, and a structure in which a size of dispersed phase is controlled to 300 nm or less, more preferably 100 nm or less is formed. | 2011-11-17 |